Speaker illustration

Doctor Luis Eduardo Echeverria

Foundation Cardiovascular of Colombia, Floridablanca (Colombia)

Impacto de la insuficiencia cardíaca causada por enfermedad de Chagas en América Latina.

Event: Heart Failure 2022

Topic: Chronic Heart Failure

Session: Perfil diferencial de la Insuficiencia Cardíaca en América Latina

Thumbnail

Adherence to the treatment guidelines in ambulatory heart failure patients with reduced ejection fraction in a Latin-American country: an observational study of the Colombian Heart Failure Registry

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Heart Failure ePosters - focus on Chronic Heart Failure 4

Thumbnail

Profile of diabetic heart failure in a latin-american country. A national registry in Colombia

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

Association between neutrophil gelatinase-associated lipocalin (NGAL) and ventricular function in patients with chagas cardiomyopathy. Nephron or cardiomyocyte?

Event: HEART FAILURE 2016

Topic: Biomarkers, other

Session: Biomarkers

Thumbnail

Cystatin C and global longitudinal strain in patients with chagas disease: just a marker of kidney function?

Event: HEART FAILURE 2016

Topic: Biomarkers, other

Session: Biomarkers

Thumbnail

Galectin 3 and chagas cardiomyopathy: relationship of this myocardial fibrosis marker with myocardial deformation measured by speckle tracking in patients with chagas disease.

Event: HEART FAILURE 2016

Topic: Biomarkers, other

Session: Biomarkers

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb